Skip to main content
MGX logo
MGX
(NASDAQ)
Metagenomi Therapeutics, Inc.
$1.35-- (--)
Loading... - Market loading

Metagenomi Therapeutics (MGX) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Metagenomi Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Metagenomi Therapeutics, Inc. (MGX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2022
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Current Assets
Cash and Cash Equivalents41.7227.39140.60184.4439.30
Short-Term Investments119.08220.92130.58177.6968.86
Cash & Short-Term Investments160.80248.31271.18362.13108.15
Accounts Receivable0.312.862.451.271.57
Inventory0.000.000.000.000.00
Other Current Assets4.436.804.643.493.19
Total Current Assets165.54257.96278.27366.90108.92
Non-Current Assets
Property, Plant & Equipment (Net)47.3857.6665.1533.2633.26
Long-Term Investments2.153.4510.687.817.81
Other Non-Current Assets6.035.5410.746.076.52
Total Non-Current Assets55.5766.6486.5747.5933.08
Total Assets221.10324.60364.84414.49141.99
Current Liabilities
Accounts Payable1.490.531.792.012.01
Short-Term Debt6.0311.183.431.520.69
Accrued Liabilities1.738.354.213.977.89
Deferred Revenue8.7022.7648.0733.9434.69
Other Current Liabilities6.720.070.459.530.90
Total Current Liabilities22.9337.3168.8648.5448.54
Non-Current Liabilities
Long-Term Debt34.6340.1944.8017.0630.28
Other Non-Current Liabilities1.952.015.081.031.03
Total Non-Current Liabilities39.5752.43431.57440.38149.36
Total Liabilities62.5189.74500.43488.9198.04
Stockholders' Equity
Common Stock0.000.000.032.540.03
Retained Earnings-310.87-223.00-144.94-76.69-76.69
Accumulated Other Comprehensive Income0.260.71-0.10-0.272.24
Additional Paid-in Capital469.20457.159.460.000.00
Shares Outstanding37.6237.4237.5337.5337.53
Total Stockholders' Equity158.60234.86-135.58-74.4343.95
Total Liabilities & Equity221.10324.60364.84414.49141.99

Frequently Asked Questions About Metagenomi Therapeutics Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is MGX's debt level?

Review Metagenomi Therapeutics's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.